Independent fund research. Built on SEC filings.

How we research funds

Mutual fund · Large Value · SEI

Arga Value Fund Investor Shares (ARUVX)

Ticker ARUVX · · Holdings as of Jun 30, 2026

Expense ratio
1.05%$105/yr per $10k
Net assets
$7.3Mall share classes
Holdings
48

Bottom line

Is ARUVX a good fund? The bottom line

ARUVX is the Investor share class of Arga Value Fund, a managed large value mutual fund from SEI.

Its expense ratio is 1.05% — about $105 a year on every $10,000 invested, more expensive than 71% of large value funds we track.

With $7.3 million in net assets and 48 holdings, its largest position is Elevance Health, Inc. (4.6%) and the top 10 make up 35.4% of the portfolio.

What to watch

  • Expensive for its category (1.05%)
  • 12b-1 marketing fee of 0.25% a year
  • Small fund ($7.3 million) — small funds are likelier to close

Updated Nov 19, 2026

What ARUVX invests in

The ARGA Value Fund (the Fund) seeks long-term capital appreciation.

Under normal circumstances, the Fund will invest at least 80% of its net assets, plus any borrowings for investment purposes, in equity securities of U.S. companies and in other financial instruments, such as shares of exchange-traded funds (ETFs), that have similar economic characteristics to such securities. This 80% investment policy can be changed by the Fund upon 60 days prior written notice to shareholders. For purposes of the 80% policy, the Fund may purchase stocks issued by companies of any size, but it typically focuses its investments on large-cap stocks. The Fund considers a company to be a U.S. company if any of the following apply: (i) its securities are traded principally in the United States; (ii) it is organized under the laws of, or has a principal office in, the United States; or (iii) while traded on any market, it derives at least 50% of its revenues or profits…

From the fund's prospectus (filed Apr 30, 2026).

What ARUVX costs

On a $10,000 investment, ARUVX's 1.05% expense ratio costs about $105 a year. The prospectus estimates $5,048 in total costs over 10 years (assuming 5% annual returns). The median large value fund charges 0.81%.

See the full ARUVX fee table →

ARUVX top 10 holdings

#Holding% of fund
1Elevance Health, Inc.4.56%
2Biomarin Pharmaceutical Inc.4.41%
3Mohawk Industries, Inc.3.93%
4T. Rowe Price Group, Inc.3.72%
5Salesforce, Inc.3.45%
6Humana Inc.3.23%
7Berkshire Hathaway Inc.3.10%
8NXP Semiconductors N.V.3.08%
9Patterson-uti Energy, Inc.2.99%
10Skyworks Solutions, Inc.2.97%

Source: SEC Form N-PORT, period ended Jun 30, 2026

The top 10 make up 35.4% of the fund. See all top 25 holdings and asset mix →

Alternatives to ARUVX

More funds like ARUVX →

ARUVX FAQ

What is the expense ratio of ARUVX?
ARUVX's expense ratio is 1.05%, which works out to about $105 a year for every $10,000 invested. The prospectus estimates total costs of $5,048 over 10 years on a $10,000 investment (assuming 5% annual returns).
Is ARUVX a good investment?
It depends on your goals, but the data points to: expensive for its category (1.05%); 12b-1 marketing fee of 0.25% a year; small fund ($7.3 million) — small funds are likelier to close. This is general information, not personalized advice.
What does ARUVX hold?
ARUVX's largest holdings are Elevance Health, Inc. (4.6%), Biomarin Pharmaceutical Inc. (4.4%), Mohawk Industries, Inc. (3.9%), T. Rowe Price Group, Inc. (3.7%), Salesforce, Inc. (3.5%). It holds 48 positions in total as of Jun 30, 2026 (SEC Form N-PORT).
Who manages ARUVX?
ARUVX is offered by SEI through Advisors' Inner Circle Fund III.